Get the content you want anytime you want.

Top 5 Contagion® News Articles for the Week of March 19, 2017


#1: Disinfectants and the Rise of the Resistant Bug 

With the discovery of 35 cases of the resistant fungal infection, Candida auris, in the United States, clinicians and public health officials have become increasingly concerned about environmental cleaning and disinfection. Particularly because C. auris is environmentally hardy, and transmissible between people. Indeed, healthcare practitioners know all-too-well the problems that can arise from such a resilient pathogen as they have been struggling to battle another hard to manage pathogen, Clostridium difficile, for years.
In fact, perhaps “triggered by the rise of C. auris, the Centers for Disease Control and Prevention (CDC) recently released new recommendations for the use of hospital-grade disinfectants effective against C. diff.”

C. diff is notorious for persisting in the environment, and therefore, special cleaning agents are required to be used for disinfection. Products that should be used must be EPA-registered against C. diff., and such items can be hard to find for use in cleaning tools such as stethoscopes or computers on wheels that go in and out of exam rooms. It is because of this that germicidal wipes with these EPA designations can be particularly helpful for clinicians. The announcement that Clorox's Healthcare Bleach Wipe as effective against 58 organisms with a three-minute wet time is particularly exciting at a time when organisms such as C. diff and C. auris are becoming more rampant. Indeed, “as new organisms are identified and existing ones become resistant to antimicrobials, the availability of strong disinfecting products has become even more pivotal.”
To read more on disinfectants in the era of the “superbug,” click here.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.

Want more information on this topic and the opportunity to ask questions of an expert? Register for a live, ACPE accredited webinar February 28th 8-9 PM EST at this link:
Big advances in treatment can